THERATECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.535 USD | -2.69% |
|
+2.33% | -5.25% |
| 07-10 | Theratechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024 | CI |
| 07-10 | Transcript : Theratechnologies Inc., Q2 2024 Earnings Call, Jul 10, 2024 |
Chart calendar Theratechnologies Inc.
31b.QvFVpnxhEtsQ_U_9HiKIxhHVtLP7hAN7CNH2DNejwhk.A7svyQwiaO9mr36uLW_8lyTm2IWVt1osfaKSSr_ujVg3sj_FUQVelUOVHg~92bae396f80417c83e44d9b7f6fea366
Upcoming events on Theratechnologies Inc.
Past events on Theratechnologies Inc.
| 10/07/2024 13:30 | Q2 2024 Earnings Call |
| 10/07/2024 12:30 | Q2 2024 Earnings Release |
| 01/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - 3081 |
| 09/05/2024 15:00 | Annual General Meeting |
| 17/04/2024 15:00 | Bloom Burton & Co. Healthcare Investor Conference |
| 10/04/2024 13:30 | Q1 2024 Earnings Call |
| 10/04/2024 12:30 | Q1 2024 Earnings Release |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract Number : 3717 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number : 2071 |
| 21/02/2024 13:30 | Q4 2023 Earnings Call |
| 21/02/2024 12:30 | Q4 2023 Earnings Release |
| 27/09/2023 13:00 | Cantor Global Healthcare Conference |
| 26/09/2023 13:30 | Q3 2023 Earnings Call |
| 26/09/2023 12:30 | Q3 2023 Earnings Release |
| 11/09/2023 05:00 | H.C. Wainwright Global Investment Conference |
| 30/07/2023 | Reverse Split: 1 of 4 |
| 12/07/2023 13:30 | Q2 2023 Earnings Call |
| 12/07/2023 12:30 | Q2 2023 Earnings Release |
| 13/06/2023 15:00 | Sudocetaxel Zendusortide Phase 1 Approval Call |
| 03/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract number : 3089 |
Annual results
| Fiscal Period | November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 84,0 83,4 0.75% | 82,7 83,9 -1.42% | 89,7 87,6 2.49% | 109 109 0.04% | 110 113 -1.84% | 120 |
|
EBITDA Million CAD | Released Forecast Spread | 0,43 8,94 -95.2% | -8,88 -8,73 -1.63% | -18,7 -6,83 -174.52% | -32,0 -35,0 8.62% | -3,94 -8,51 53.73% | 20,4 |
|
EBIT Million CAD | Released Forecast Spread | -11,3 -6,11 -85.1% | -22,5 -23,6 4.66% | -32,4 -29,4 -10.16% | -54,2 -54,0 -0.34% | -14,4 -27,2 47.18% | 14,8 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -16,6 -4,37 -279.97% | -28,4 -24,7 -15.01% | -40,7 -34,1 -19.18% | -63,6 -62,2 -2.25% | -31,8 -40,2 20.94% | 4,50 |
|
Net income Million CAD | Released Forecast Spread | -16,6 -7,55 -120.06% | -28,4 -24,7 -15.01% | -40,8 -28,9 -40.85% | -64,2 -63,5 -0.98% | -32,4 -38,8 16.64% | 0,20 |
|
EPS CAD | Released Forecast Spread | -0,85 -0,38 -121.47% | -1,50 -1,11 -35.54% | -1,75 -1,29 -35.91% | -2,72 -2,57 -6% | -1,23 -1,20 -2.09% | 0,01 |
| Announcement Date | 25/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | November | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 25,0 26,2 -4.55% | 28,7 28,0 2.43% | 29,1 29,1 0.07% | 26,8 29,2 -8.08% | 23,3 29,3 -20.65% | 28,1 28,2 -0.38% | 31,7 31,5 0.76% | 22,1 26,2 -15.84% | 30,0 29,6 1.47% | 32,6 | 35,5 | 31,4 | 33,7 | 34,8 |
|
EBITDA Million CAD | Released Forecast Spread | -15,2 -8,53 -77.75% | -5,24 0,00 -128427.7% | -8,09 -1,58 -413.17% | 2,91 -3,84 175.69% | 6,70 1,92 248.46% | -0,34 -0,24 -41.92% | 6,22 | 6,94 | ||||||
|
EBIT Million CAD | Released Forecast Spread | -27,2 -10,2 -167.46% | -7,61 -19,7 61.27% | -7,75 -7,74 -0.16% | -7,29 -4,83 -50.9% | -10,5 -5,14 -105.18% | 0,07 -7,07 101.03% | 3,61 -9,07 139.79% | -3,05 -2,93 -4.35% | 4,92 2,63 86.99% | 5,61 | 7,75 | 7,71 | 7,78 | 8,09 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -29,3 -11,3 -158.22% | -10,2 -20,7 50.63% | -10,6 -9,38 -12.74% | -13,9 -6,90 -101.97% | -13,1 -6,68 -96.45% | -0,84 -9,71 91.38% | -3,62 -11,8 69.32% | -5,94 -6,58 9.77% | 1,51 -0,54 377.82% | 2,98 | 5,99 | 4,36 | 4,62 | 5,13 |
|
Net income Million CAD | Released Forecast Spread | -29,5 -11,3 -159.61% | -10,4 -20,7 49.62% | -10,8 -9,38 -14.81% | -14,1 -6,90 -103.84% | -13,3 -6,63 -100.29% | -1,01 -9,67 89.57% | -3,72 -11,5 67.49% | -6,09 -6,58 7.5% | 1,35 -0,61 320.34% | 2,07 | 3,95 | 3,89 | 4,12 | 4,58 |
|
EPS CAD | Released Forecast Spread | -1,26 -0,49 -157.43% | -0,44 -0,65 32.09% | -0,49 -0,40 -23.27% | -0,59 -0,27 -117.56% | -0,53 -0,27 -98.55% | -0,04 -0,39 89.61% | -0,04 -0,43 90.55% | -0,14 -0,19 28.21% | 0,03 -0,02 220.38% | 0,04 | 0,08 | 0,01 | 0,03 | 0,05 |
| Announcement Date | 14/07/22 | 13/10/22 | 28/02/23 | 12/04/23 | 12/07/23 | 26/09/23 | 21/02/24 | 10/04/24 | 10/07/24 | - | - | - | - | - |
| 23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
| 25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release |
| 29/07/2024 | BIOTEST AG: Q2 2024 Earnings Release |
| 30/07/2024 12:00 | INCYTE CORPORATION: Q2 2024 Earnings Release |
| 30/07/2024 | VERICEL CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Theratechnologies Inc.
| 16/07/2024 10:17 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 11/07/2024 11:30 | KALVISTA PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 23/05/2024 10:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 13/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TH Stock
- THTX Stock
- Calendar Theratechnologies Inc.
